Literature DB >> 1639510

Characterization of the humoral response induced by a peptide corresponding to variable domain IV of the major outer membrane protein of Chlamydia trachomatis serovar E.

X Cheng1, S Pal, L M de la Maza, E M Peterson.   

Abstract

A 30-amino-acid peptide corresponding to variable domain IV (VD IV) of the major outer membrane protein of Chlamydia trachomatis serovar E was conjugated to keyhole limpet hemocyanin (KLH) and used to immunize mice. The resulting antisera (anti-KLH-VD IV sera) recognized all 15 serovars of C. trachomatis when assayed by indirect immunofluorescence and Western blotting. Probing of overlapping hexameric peptides representing VD IV with mouse anti-KLH-VD IV sera revealed that two main regions of the peptide were recognized by the antisera, the N terminus of the peptide, which contains B-complex-specific epitopes, and the middle region of the peptide, which contains a species-conserved domain. When used in an in vitro neutralization assay, these antisera were able to neutralize mainly serovars in the B complex. These data provide evidence that a linear peptide corresponding to VD IV can induce in vitro protection from C. trachomatis infectivity that is subspecies specific.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1639510      PMCID: PMC257331          DOI: 10.1128/iai.60.8.3428-3432.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  Mapping antigenic domains expressed by Chlamydia trachomatis major outer membrane protein genes.

Authors:  W Baehr; Y X Zhang; T Joseph; H Su; F E Nano; K D Everett; H D Caldwell
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

2.  Strategies for epitope analysis using peptide synthesis.

Authors:  H M Geysen; S J Rodda; T J Mason; G Tribbick; P G Schoofs
Journal:  J Immunol Methods       Date:  1987-09-24       Impact factor: 2.303

3.  Protective monoclonal antibodies to Chlamydia trachomatis serovar- and serogroup-specific major outer membrane protein determinants.

Authors:  Y X Zhang; S J Stewart; H D Caldwell
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

4.  Epitope mapping with solid-phase peptides: identification of type-, subspecies-, species- and genus-reactive antibody binding domains on the major outer membrane protein of Chlamydia trachomatis.

Authors:  J W Conlan; I N Clarke; M E Ward
Journal:  Mol Microbiol       Date:  1988-09       Impact factor: 3.501

5.  Nucleotide and deduced amino acid sequences for the four variable domains of the major outer membrane proteins of the 15 Chlamydia trachomatis serovars.

Authors:  Y Yuan; Y X Zhang; N G Watkins; H D Caldwell
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

6.  Cloning and characterization of a Chlamydia trachomatis L3 DNA fragment that codes for an antigenic region of the major outer membrane protein and specifically hybridizes to the C- and C-related-complex serovars.

Authors:  E J Carlson; E M Peterson; L M de la Maza
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

7.  Comparison of a single-antigen microimmunofluorescence assay and inclusion fluorescent-antibody assay for detecting chlamydial antibodies and correlation of the results with neutralizing ability.

Authors:  E M Peterson; R Oda; P Tse; C Gastaldi; S C Stone; L M de la Maza
Journal:  J Clin Microbiol       Date:  1989-02       Impact factor: 5.948

8.  Cognitive features of continuous antigenic determinants.

Authors:  H M Geysen; T J Mason; S J Rodda
Journal:  J Mol Recognit       Date:  1988-02       Impact factor: 2.137

9.  Expression of Fc gamma RIII on HeLa 229 cells: possible effect on in vitro neutralization of Chlamydia trachomatis.

Authors:  H Su; G J Spangrude; H D Caldwell
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

10.  High-resolution mapping of serovar-specific and common antigenic determinants of the major outer membrane protein of Chlamydia trachomatis.

Authors:  R S Stephens; E A Wagar; G K Schoolnik
Journal:  J Exp Med       Date:  1988-03-01       Impact factor: 14.307

View more
  6 in total

1.  Vaccination with the Chlamydia trachomatis major outer membrane protein can elicit an immune response as protective as that resulting from inoculation with live bacteria.

Authors:  Sukumar Pal; Ellena M Peterson; Luis M de la Maza
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

2.  Effect of immunoglobulin G isotype on the infectivity of Chlamydia trachomatis in a mouse model of intravaginal infection.

Authors:  E M Peterson; X Cheng; V L Motin; L M de la Maza
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

3.  Characterization of a neutralizing monoclonal antibody directed at variable domain I of the major outer membrane protein of Chlamydia trachomatis C-complex serovars.

Authors:  Z Qu; X Cheng; L M de la Maza; E M Peterson
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

Review 4.  Vaccines for bacterial sexually transmitted infections: a realistic goal?

Authors:  P F Sparling; C Elkins; P B Wyrick; M S Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

5.  Benzylidene acylhydrazides inhibit chlamydial growth in a type III secretion- and iron chelation-independent manner.

Authors:  Xiaofeng Bao; Asa Gylfe; Gail L Sturdevant; Zheng Gong; Shuang Xu; Harlan D Caldwell; Mikael Elofsson; Huizhou Fan
Journal:  J Bacteriol       Date:  2014-06-09       Impact factor: 3.490

6.  Effects of antibody isotype and host cell type on in vitro neutralization of Chlamydia trachomatis.

Authors:  E M Peterson; X Cheng; S Pal; L M de la Maza
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.